Skip to main content

and
  1. Article

    Open Access

    Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

    We report a multi-ancestry genome-wide association study on liver cirrhosis and its associated endophenotypes, alanine aminotransferase (ALT) and γ-glutamyl transferase. Using data from 12 cohorts, including 1...

    Jonas Ghouse, Gardar Sveinbjörnsson, Marijana Vujkovic in Nature Genetics (2024)

  2. No Access

    Article

    Angioplasty Induced Changes in Dialysis Vascular Access Compliance

    Dialysis vascular access remains vitally important to maintain life and functional capacity with end stage renal disease. Angioplasty is an integral part of maintaining dialysis access function and patency. To...

    Yihao Zheng, Brian J. Thelen, Nirmala Rajaram in Annals of Biomedical Engineering (2021)

  3. Article

    Open Access

    Impact of underground storm drain systems on larval ecology of Culex and Aedes species in urban environments of Southern California

    An extensive network of storm water conveyance systems in urban areas, often referred to as the “underground storm drain system” (USDS), serves as significant production habitats for mosquitoes. Knowledge of w...

    **aoming Wang, Guofa Zhou, Daibin Zhong, Yiji Li, Stacia Octaviani in Scientific Reports (2021)

  4. No Access

    Article

    CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation

    In this study cannabidiol (CBD) was administered orally to determine its effects and mechanisms in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). We hypothesized that 75 ...

    James M. Nichols, Evangel Kummari, Jessica Sherman in Journal of Neuroimmune Pharmacology (2021)

  5. Article

    Open Access

    Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans

    Cirrhosis is a rapidly increasing cause of global mortality. To improve cirrhosis care, the Veterans Health Administration (VHA) developed the Hepatic Innovation Team (HIT) Collaborative to support VA Medical...

    Shari S. Rogal, Vera Yakovchenko, Timothy Morgan in Implementation Science (2020)

  6. No Access

    Article

    Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders

    As the era of interferon-alpha (IFN)-based therapy for hepatitis C ends, long-term treatment outcomes are now being evaluated.

    Myrna L. Cozen, James C. Ryan, Hui Shen, Ramsey Cheung in Digestive Diseases and Sciences (2016)

  7. Article

    Open Access

    The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population

    Ingestion of polyunsaturated fatty acids (PUFAs) has been proposed to influence several chronic diseases including coronary heart disease (CHD) and type-2 diabetes (T2D). There is strong evidence that omega-3 ...

    Tammy C Lee, Priscilla Ivester, Austin G Hester in Lipids in Health and Disease (2014)

  8. No Access

    Article

    Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view

    Since the late nineteenth century, protein restriction has been shown to improve hepatic encephalopathy. However, malnutrition has been described in up to 60 % of cirrhotic patients and is associated with incr...

    Douglas L. Nguyen, Timothy Morgan in Hepatology International (2014)

  9. Article

    Open Access

    High rates of early treatment discontinuation in hepatitis C-infected US veterans

    Patients with chronic hepatitis C (HCV) frequently discontinued dual therapy with pegylated interferon alfa (Peg-IFN) plus ribavirin (RBV) before reaching the recommended duration of 48 or 24 weeks for genotyp...

    Joanne LaFleur, Robert Hoop, Timothy Morgan, Scott L DuVall in BMC Research Notes (2014)

  10. Article

    Open Access

    Testing Beneficial Therapy in Human Cirrhosis Using Animal Models of Cirrhosis

    John Carl Hoefs, Timothy Morgan, Bernard Joseph Ilagan in Digestive Diseases and Sciences (2011)

  11. Article

    Open Access

    Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors

    Surrogate measures for cardiovascular disease events have the potential to increase greatly the efficiency of clinical trials. A leading candidate for such a surrogate is the progression of intima-media thickn...

    Mark A Espeland, Daniel H O'Leary in Current Controlled Trials in Cardiovascula… (2005)

  12. No Access

    Article

    Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis

    The filamins are cytoplasmic proteins that regulate the structure and activity of the cytoskeleton by cross-linking actin into three-dimensional networks, linking the cell membrane to the cytoskeleton and serv...

    Deborah Krakow, Stephen P Robertson, Lily M King, Timothy Morgan in Nature Genetics (2004)

  13. No Access

    Article

    Examining the Impact of Missing Data on Propensity Score Estimation in Determining the Effectiveness of Self-Monitoring of Blood Glucose (SMBG)

    In many health services applications, research to determine the effectiveness of a particular treatment cannot be carried out using a controlled clinical trial. In settings such as these, observational studies...

    Ralph D'Agostino Jr., Wei Lang in Health Services and Outcomes Research Meth… (2001)